Skip to content
Screener

Harmony Biosciences Holdings, Inc. HRMY Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$161.5M+77.2%
Alkermes logo
AlkermesALKS
$68.02M+21.4%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$991K-47.1%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$41.46M+26.1%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$15.31M-46.4%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$2.09M-37.1%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$2.24B+11.7%
Enterprise value$1.81B+11.2%
P/E15.4×+4.3×
P/S2.5×-0.1×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 8:16 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056720
Line itemMarch 31, 2026December 31, 2025
Total current liabilities217,340252,132
NONCURRENT LIABILITIES:
Long-term debt, net138,814143,663
Other noncurrent liabilities5,3215,618
Total noncurrent liabilities144,135149,281
TOTAL LIABILITIES361,475401,413
COMMITMENTS AND CONTINGENCIES (Note 13)
STOCKHOLDERS’ EQUITY:

Item 1. Financial Statements

FAQ

What is Harmony Biosciences Holdings, Inc.'s other non-current liabilities?
Harmony Biosciences Holdings, Inc. (HRMY) reported other non-current liabilities of $5.32M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s other non-current liabilities changed year-over-year?
Harmony Biosciences Holdings, Inc.'s other non-current liabilities increased by 211.2% year-over-year, from $1.71M to $5.32M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s other non-current liabilities?
Over 5 years (2020 to 2025), Harmony Biosciences Holdings, Inc.'s other non-current liabilities has grown at a 38.4% compound annual growth rate (CAGR), from $1.11M to $5.62M.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about Harmony Biosciences Holdings, Inc.'s other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude